Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-07-08 | Amended | $270,000,000 | $53,000,000 | Equity Only | 06b | SEC link |
| 2025-03-25 | Amended | $217,000,000 | $32,000,000 | Equity Only | 06b | SEC link |
| 2022-11-10 | Amended | $185,000,000 | $0 | Equity Only | 06b | SEC link |
| 2022-11-04 | New | $25,000,000 | $25,000,000 | Debt Only | 06b | SEC link |
| 2022-11-04 | New | $185,000,000 | $185,000,000 | Equity Only | 06b | SEC link |
| 2021-03-12 | New | $35,000,010 | $35,000,010 | Equity Only | 06b | SEC link |
| 2021-03-12 | Amended | $35,000,010 | $0 | Equity Only | 06b | SEC link |
| 2019-10-03 | New | $37,423,356 | $37,423,356 | Equity Only | 06b | SEC link |
| 2018-12-07 | Amended | $9,375,000 | $2,450,000 | Equity Only | 06b | SEC link |
| 2018-08-14 | New | $6,925,000 | $6,925,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Jeffrey Aronin | Director |
| Timothy Cunniff | Director |
| Jeffrey Dayno | Director |
| Antonio Gracias | Director |
| Eric Messner | Director, Executive |
| Patrick J. Morris | Executive |
| Darien Parhad | Executive |
| Ricky Sun | Director |